| Description: | Mediforum is the first pharmaceutical company in the world to reach the 3rd and final clinical trial phase in South Korea for its Myungmin PM-012 formula for the treatment of Alzheimer's dementia. In cooperation with the leading university on traditional Korean medicine, we have developed safe and natural drugs that help with memory loss, enhance coordination and concentration, combat depression, dementia and Alzheimer's. Unlike the current drugs on the market offered for fighting dementia that come with a long list of severe side-effects, our products not only combat the condition itself, but works in synergy with your body to provide you better overall health. Seeing as to how the progression of Alzheimer’s will become the single greatest economic burden on societies around the world, we strive to make a great impact to keep that at bay. |
